108 Participants Needed

COPE2Thrive Program for Adolescent Mental Health

Recruiting at 4 trial locations
MW
AO
MD
EC
Overseen ByEleanor C Richards, PhD
Age: < 65
Sex: Any
Trial Phase: Phase 1
Sponsor: Cambridge Health Alliance
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial uses an online tool to identify mental health issues early and offers support to help high-risk youth from diverse backgrounds build resilience. It aims to provide activities that help manage stress, especially for those who often face barriers to getting mental health care.

Will I have to stop taking my current medications?

The trial protocol does not specify whether participants must stop taking their current medications. However, students already receiving behavioral health care are excluded from the study, which might imply that those on certain medications could be ineligible.

What data supports the effectiveness of the COPE2Thrive treatment for adolescent mental health?

The COPE program, which is part of the COPE2Thrive treatment, has been shown to help depressed and anxious teens by teaching them skills to manage their feelings in short, 30-minute sessions.12345

What makes the COPE2Thrive treatment unique for adolescent mental health?

The COPE2Thrive treatment is unique because it combines elements of peer-to-peer support and online interventions, making mental health care more accessible and engaging for adolescents. This approach is different from traditional treatments as it leverages technology and peer interactions to improve help-seeking behaviors and coping skills among young people.678910

Research Team

BC

Benjamin Cook, PhD

Principal Investigator

Health Equity Research Lab

Eligibility Criteria

This trial is for high school students in certain areas who speak English, Haitian Creole, Portuguese, or Spanish and show moderate symptoms of mental health issues. It excludes seniors, those already in therapy, or urgently suicidal individuals.

Inclusion Criteria

Youth who have completed WFIRS and K-CAT, and who do not meet the exclusion criteria
High school students in CHA's catchment area (Cambridge, Chelsea, Everett, Malden, Revere, Somerville, Winthrop)
Youth who are fluent in English, Haitian-Creole, Portuguese, or Spanish

Exclusion Criteria

Students who are considered to be seriously suicidal and in need of urgent care
Students who are already receiving behavioral health care
I am in the 12th grade.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person or virtual)

Intervention

Participants receive the COPE2Thrive resilience-based digital intervention

23 weeks
Weekly check-ins (virtual)

Follow-up

Participants are monitored for safety and effectiveness after intervention

3 months

Treatment Details

Interventions

  • Cope2Thrive
  • COPE2Thrive
  • Usual care
Trial OverviewThe study tests COPE2Thrive—a preventive intervention against usual care—to improve adolescent wellbeing and resilience in diverse communities during a healthcare crisis.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: R34#1 Aim 2 COPE2Thrive InterventionExperimental Treatment1 Intervention
Randomly clustered youth who have completed the screening will be randomized to receive a resilience based digital intervention, COPE2Thrive.
Group II: Control armActive Control1 Intervention
The comparator arm is treatment as usual. For each monthly crossover, 12 students in a cluster are eligible to receive C2T in a stepped wedge study design. Student outcomes prior to receiving C2T will be compared to outcomes after receiving C2T.

Cope2Thrive is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Lynparza for:
  • Ovarian cancer
  • Breast cancer
  • Fallopian tube cancer
  • Peritoneal cancer
  • Pancreatic cancer
  • Prostate cancer
🇺🇸
Approved in United States as Lynparza for:
  • Ovarian, fallopian tube, and primary peritoneal cancer
  • Breast cancer
  • Prostate cancer
  • Pancreatic cancer
🇨🇦
Approved in Canada as Lynparza for:
  • Ovarian cancer
  • Breast cancer
  • Pancreatic cancer
  • Prostate cancer

Find a Clinic Near You

Who Is Running the Clinical Trial?

Cambridge Health Alliance

Lead Sponsor

Trials
65
Recruited
22,400+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Findings from Research

The COPE program is an evidence-based cognitive-behavioral therapy designed for depressed and anxious teens, delivered in brief 30-minute outpatient visits, making it suitable for busy clinical settings.
This program allows advanced practice nurses to effectively utilize their skills to provide timely mental health support to adolescents, enhancing their ability to address common mental health issues in various environments like psychiatric and primary care settings.
COPE for depressed and anxious teens: a brief cognitive-behavioral skills building intervention to increase access to timely, evidence-based treatment.Lusk, P., Melnyk, BM.[2021]
A study of 3098 children and adolescents receiving treatment at Child and Youth Mental Health Services in Brisbane revealed that anxiety and mood disorders were the most prevalent, with many patients experiencing multiple disorders and psychosocial stressors.
While there was a significant improvement in mental health symptoms during treatment, with effect sizes around 0.9, about 50% of the participants still had clinical-level symptoms at the end, indicating a need for enhanced treatment strategies to further reduce these symptoms.
Characteristics and treatment outcomes of children and adolescents accessing treatment in Child and Youth Mental Health Services.Lu, ZQ., de Geus, H., Roest, S., et al.[2023]
The CYP-IAPT programme aimed to improve Child and Adolescent Mental Health Services in England but faced challenges due to unclear definitions and guidance on how to implement its principles effectively, as revealed by an analysis of 275 documents and interviews with CAMHS professionals.
Staff interviews highlighted a lack of coherent understanding and variable investment in the programme, which created barriers to effective collaboration and implementation, ultimately affecting the sustainability of the initiative in Cambridgeshire.
Evaluating the CYP-IAPT transformation of child and adolescent mental health services in Cambridgeshire, UK: a qualitative implementation study.Burn, AM., Vainre, M., Humphrey, A., et al.[2022]

References

COPE for depressed and anxious teens: a brief cognitive-behavioral skills building intervention to increase access to timely, evidence-based treatment. [2021]
Characteristics and treatment outcomes of children and adolescents accessing treatment in Child and Youth Mental Health Services. [2023]
Evaluating the CYP-IAPT transformation of child and adolescent mental health services in Cambridgeshire, UK: a qualitative implementation study. [2022]
Teaching kids to cope: a preventive mental health nursing strategy for adolescents. [2019]
Ziprasidone in adolescents with schizophrenia: results from a placebo-controlled efficacy and long-term open-extension study. [2022]
@ease peer-to-peer youth walk-in centres in The Netherlands: A protocol for evaluating longitudinal outcomes, follow-up results and cost-of-illness. [2023]
Promoting positive coping skills for rural youth: benefits for at-risk young people. [2009]
Editorial Promoting Help-seeking using E-Technology for ADolescents: The ProHEAD consortium. [2020]
Facilitating mental health help-seeking by young adults with a dedicated online program: a feasibility study of Link. [2019]
A retrospective audit of referrals of 16-17 year olds with reference to substance abuse. [2016]